Abstract:Irreversible electroporation (IRE) is a relatively new ablation technique for the treatment of abdominal and extra-abdominal tumors. Its working mechanism is essentially non thermal as, through the insertion of probes into the neoplasm during open laparotomy or percutaneously under ultrasound (US) or computed tomography (CT) guidance, it delivers high voltage electric pulses into the target lesion. The resultant electric field causes the formation of nanopores in the cell membrane of neoplastic cells with consequent apoptosis and cell death. The effect of IRE is limited to the cell membrane; for this reason, the adjacent extracellular matrix structures are preserved and this makes this technique a theoretically safe option for tumors located next to blood vessels, bowel loops, urethra (in the case of prostatic cancer) and major bile ducts (in the case of hepatic tumors). IRE ablation must be performed under general anesthesia, total muscle paralysis and continuous vital signs monitoring to avoid the muscle spasm related to the excitation of the motor neural end-plate, and to monitor and treat the possible cardiac arrhythmias caused by the increased cell membrane permeability [1, 2].

Irreversible electroporation for hepatic tumors